Correlation Between ING Bank and Medicofarma Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ING Bank and Medicofarma Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ING Bank and Medicofarma Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ING Bank lski and Medicofarma Biotech SA, you can compare the effects of market volatilities on ING Bank and Medicofarma Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ING Bank with a short position of Medicofarma Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of ING Bank and Medicofarma Biotech.

Diversification Opportunities for ING Bank and Medicofarma Biotech

-0.72
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between ING and Medicofarma is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding ING Bank lski and Medicofarma Biotech SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicofarma Biotech and ING Bank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ING Bank lski are associated (or correlated) with Medicofarma Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicofarma Biotech has no effect on the direction of ING Bank i.e., ING Bank and Medicofarma Biotech go up and down completely randomly.

Pair Corralation between ING Bank and Medicofarma Biotech

Assuming the 90 days trading horizon ING Bank lski is expected to generate 0.41 times more return on investment than Medicofarma Biotech. However, ING Bank lski is 2.44 times less risky than Medicofarma Biotech. It trades about 0.11 of its potential returns per unit of risk. Medicofarma Biotech SA is currently generating about -0.07 per unit of risk. If you would invest  27,300  in ING Bank lski on November 28, 2024 and sell it today you would earn a total of  1,650  from holding ING Bank lski or generate 6.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

ING Bank lski  vs.  Medicofarma Biotech SA

 Performance 
       Timeline  
ING Bank lski 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ING Bank lski are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, ING Bank reported solid returns over the last few months and may actually be approaching a breakup point.
Medicofarma Biotech 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Medicofarma Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

ING Bank and Medicofarma Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ING Bank and Medicofarma Biotech

The main advantage of trading using opposite ING Bank and Medicofarma Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ING Bank position performs unexpectedly, Medicofarma Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicofarma Biotech will offset losses from the drop in Medicofarma Biotech's long position.
The idea behind ING Bank lski and Medicofarma Biotech SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets